Immune-mediated disease pathogenesis in respiratory syncytial virus infection

Author： Graham B.S.   Johnson T.R.   Peebles R.S.  

Publisher： Elsevier

ISSN： 0162-3109

Source： Immunopharmacology, Vol.48, Iss.3, 2000-07, pp. : 237-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection

By McDermott Daniel S   Weiss Kayla A   Knudson Cory J   Varga Steven M  

Future Virology, Vol. 6, Iss. 8, 2011-08 ,pp. : 963-973

Future Medicine

Access to resources Recommend Favorite

Emerging drugs for respiratory syncytial virus infection

By Olszewska Wieslawa   Openshaw Peter  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite

Respiratory Syncytial Virus Infection in Elderly Adults

By Falsey Ann R.   Walsh Edward E.  

Drugs & Aging, Vol. 22, Iss. 7, 2005-01 ,pp. : 577-587

Adis International

Access to resources Recommend Favorite

Respiratory Syncytial Virus Infection in Adult Populations

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 2, 2012-04 ,pp. : 98-102

Bentham Science Publishers

Access to resources Recommend Favorite

Palivizumab: A Review of its Use as Prophylaxis for Serious Respiratory Syncytial Virus Infection

By Fenton Caroline   Scott Lesley J.   Plosker Greg L.  

Pediatric Drugs, Vol. 6, Iss. 3, 2004-01 ,pp. : 177-197

Adis International

Access to resources Recommend Favorite